• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于国际浆液性液体细胞病理学报告系统的胸腔积液细胞组织学相关性

Cytohistological Correlation in Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology.

作者信息

Pinto Daniel, Cruz Eduardo, Branco Diamantina, Linares Cláudia, Carvalho Conceição, Silva Amélia, Chorão Martinha, Schmitt Fernando

机构信息

Serviço de Anatomia Patológica, Centro Hospitalar de Lisboa Ocidental, EPE, 1349-019 Lisboa, Portugal.

NOVA Medical School, 1169-056 Lisboa, Portugal.

出版信息

Diagnostics (Basel). 2021 Jun 20;11(6):1126. doi: 10.3390/diagnostics11061126.

DOI:10.3390/diagnostics11061126
PMID:34203073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235437/
Abstract

The International System for Reporting Serous Fluid Cytology (TIS) was recently developed. Given its novelty, most studies looking into the risk of malignancy (ROM) of serous effusion diagnostic categories were published before the development of TIS. We searched the database of our department for pleural effusions diagnosed in the last five years, excluding those without a corresponding pleural biopsy. Cases were reviewed and reclassified according to the TIS. A cytohistological correlation was performed. In total, 350 pleural effusion specimens with one or more corresponding pleural biopsies were included. After reclassification, 5 (1.43%) were nondiagnostic (ND), 253 (72.29%) were negative for malignancy (NFM), 7 (2.00%) had atypia of unknown significance (AUS), 14 (4.00%) were suspicious for malignancy (SFM), and 71 (20.57%) were malignant (MAL). Calculated ROM was 40% for ND, 20.16% for NFM, 42.86% for AUS, 78.57% for SFM, and 100% for MAL. Effusion cytology sensitivity and specificity were 60.29% and 98.56%, respectively. This is the first publication looking into the cytohistological correlation of a retrospective cohort of pleural effusions based on the TIS. We add to the body of data regarding the ROM for TIS categories, highlighting areas of potential future research.

摘要

国际浆液性液体细胞学报告系统(TIS)最近得以开发。鉴于其新颖性,大多数探究浆液性积液诊断类别恶性风险(ROM)的研究是在TIS开发之前发表的。我们在本部门数据库中搜索了过去五年诊断的胸腔积液病例,排除了那些没有相应胸膜活检的病例。根据TIS对病例进行复查和重新分类。进行了细胞组织学相关性分析。总共纳入了350份有一份或多份相应胸膜活检的胸腔积液标本。重新分类后,5例(1.43%)为无法诊断(ND),253例(72.29%)为恶性阴性(NFM),7例(2.00%)为意义不明的非典型性(AUS),14例(4.00%)为恶性可疑(SFM),71例(20.57%)为恶性(MAL)。计算得出的ND的ROM为40%,NFM为20.16%,AUS为42.86%,SFM为78.57%,MAL为100%。积液细胞学的敏感性和特异性分别为60.29%和98.56%。这是第一篇基于TIS对胸腔积液回顾性队列进行细胞组织学相关性分析的出版物。我们补充了有关TIS类别ROM的数据,突出了未来潜在的研究领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1045/8235437/2ae5c3d48ff8/diagnostics-11-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1045/8235437/93fda6061537/diagnostics-11-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1045/8235437/2ae5c3d48ff8/diagnostics-11-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1045/8235437/93fda6061537/diagnostics-11-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1045/8235437/2ae5c3d48ff8/diagnostics-11-01126-g002.jpg

相似文献

1
Cytohistological Correlation in Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology.基于国际浆液性液体细胞病理学报告系统的胸腔积液细胞组织学相关性
Diagnostics (Basel). 2021 Jun 20;11(6):1126. doi: 10.3390/diagnostics11061126.
2
Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.国际浆膜腔液细胞病理学报告系统对不同浆膜腔积液良恶性病因的综合评估:台湾的一项多机构研究。
Cancer Cytopathol. 2024 Mar;132(3):169-178. doi: 10.1002/cncy.22783. Epub 2023 Dec 8.
3
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.国际浆液性液体细胞病理学报告系统在细胞组织学相关性及恶性风险评估中的应用
Diagnostics (Basel). 2021 Nov 28;11(12):2223. doi: 10.3390/diagnostics11122223.
4
Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.国际浆膜腔液细胞病理学报告系统(TIS)的应用:一项回顾性机构研究。
Cytopathology. 2022 May;33(3):305-311. doi: 10.1111/cyt.13113. Epub 2022 Mar 7.
5
Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.浆膜腔积液的细胞组织学相关性应用新提出的国际浆膜腔液细胞病理学报告系统:肿瘤中心的经验。
Diagn Cytopathol. 2021 May;49(5):596-605. doi: 10.1002/dc.24440. Epub 2020 Apr 27.
6
Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.国际浆液性液体细胞病理学报告系统的恶性肿瘤风险评估:社区医院环境中的经验及与其他研究的比较。
Cancer Cytopathol. 2022 Dec;130(12):964-973. doi: 10.1002/cncy.22638. Epub 2022 Aug 22.
7
A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.基于新提出的国际浆膜腔液细胞学报告系统的浆膜腔积液回顾性分析:肿瘤中心 3633 例病例报告。
Diagn Pathol. 2022 Jul 2;17(1):56. doi: 10.1186/s13000-022-01241-4.
8
Application of the international system for reporting serous fluid cytopathology on pleural effusion cytology with paired pleural biopsy: A new insight and novel approach on risk of malignancy.国际浆膜腔液细胞病理学报告系统在胸腔积液细胞学与胸膜活检配对中的应用:恶性肿瘤风险的新见解和新方法。
Cytopathology. 2024 Nov;35(6):695-705. doi: 10.1111/cyt.13423. Epub 2024 Aug 1.
9
Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.新发布的国际浆膜腔液细胞病理学报告系统在非典型和可疑诊断中的应用:一项四年回顾性分析。
J Am Soc Cytopathol. 2024 Jul-Aug;13(4):303-308. doi: 10.1016/j.jasc.2024.03.001. Epub 2024 Mar 19.
10
The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.国际浆液性液体细胞病理学报告系统:关于其在积液细胞学中恶性风险评估及意义的机构经验
J Cytol. 2023 Oct-Dec;40(4):159-164. doi: 10.4103/joc.joc_111_22. Epub 2023 Oct 16.

引用本文的文献

1
Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.细胞数量不足:报告系统如何反映细胞学标本不足——从贝塞斯达报告系统到世界卫生组织报告系统的历程
Acta Cytol. 2025 Jun 17:1-12. doi: 10.1159/000546947.
2
The Role of Immunohistochemistry in Reducing the "Atypia of Undetermined Significance (AUS)" Category in Serous Fluid Cytology.免疫组织化学在减少浆液性液体细胞学中“意义未明的非典型性(AUS)”类别方面的作用。
J Cytol. 2025 Jan-Mar;42(1):43-47. doi: 10.4103/joc.joc_212_23. Epub 2025 Feb 11.
3
The International System for Reporting Serous Fluid Cytopathology-An Updated Review.

本文引用的文献

1
The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.在评估不确定的浆膜液恶性肿瘤风险中,分层细胞学诊断报告系统的价值。
Cancer Cytopathol. 2021 Jan;129(1):75-82. doi: 10.1002/cncy.22345. Epub 2020 Aug 18.
2
The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.国际浆膜腔液细胞病理学报告系统-诊断类别和临床管理。
J Am Soc Cytopathol. 2020 Nov-Dec;9(6):469-477. doi: 10.1016/j.jasc.2020.05.015. Epub 2020 Jun 9.
3
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
国际浆液性液体细胞病理学报告系统——最新综述
J Clin Transl Pathol. 2023;3(4):160-177. doi: 10.14218/jctp.2023.00025. Epub 2023 Dec 20.
4
Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".辅助技术在浆液性液体细胞学报告中的作用——“重新定义类别,优化诊断”
J Cytol. 2024 Apr-Jun;41(2):96-104. doi: 10.4103/joc.joc_114_23. Epub 2024 Apr 24.
5
The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.新型分层报告系统在浆液性液体细胞学及恶性风险评估中的作用:一项三级医疗中心的回顾性研究
J Cytol. 2023 Jul-Sep;40(3):107-113. doi: 10.4103/joc.joc_107_22. Epub 2023 Aug 14.
6
Cyto-Histopathological Correlations in Pathology Diagnostics.病理学诊断中的细胞组织病理学相关性
Diagnostics (Basel). 2022 Jul 13;12(7):1703. doi: 10.3390/diagnostics12071703.
7
A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation.3026 例胸膜活检与配对胸腔积液细胞学检查的诊断准确性比较研究,并与临床相关性进行比较。
Cancer Med. 2023 Jan;12(2):1471-1481. doi: 10.1002/cam4.5038. Epub 2022 Jul 18.
8
A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.基于新提出的国际浆膜腔液细胞学报告系统的浆膜腔积液回顾性分析:肿瘤中心 3633 例病例报告。
Diagn Pathol. 2022 Jul 2;17(1):56. doi: 10.1186/s13000-022-01241-4.
9
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.国际浆液性液体细胞病理学报告系统在细胞组织学相关性及恶性风险评估中的应用
Diagnostics (Basel). 2021 Nov 28;11(12):2223. doi: 10.3390/diagnostics11122223.
国际浆膜液细胞病理学报告系统(ISRSFC)在心包积液细胞学报告中的应用。
Acta Cytol. 2020;64(5):477-485. doi: 10.1159/000507311. Epub 2020 May 18.
4
Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.浆膜腔积液的细胞组织学相关性应用新提出的国际浆膜腔液细胞病理学报告系统:肿瘤中心的经验。
Diagn Cytopathol. 2021 May;49(5):596-605. doi: 10.1002/dc.24440. Epub 2020 Apr 27.
5
Current applications of molecular testing on body cavity fluids.体腔液分子检测的当前应用。
Diagn Cytopathol. 2020 Sep;48(9):840-851. doi: 10.1002/dc.24410. Epub 2020 Mar 30.
6
Proceedings of the American Society of Cytopathology Companion Session at the 2019 United States and Canadian Academy of Pathology Meeting Part 1: towards an International System for Reporting Serous Fluid Cytopathology.2019年美国和加拿大病理学会会议上美国细胞病理学会配套会议论文集 第1部分:迈向浆液性液体细胞病理学报告国际体系
J Am Soc Cytopathol. 2019 Nov-Dec;8(6):362-368. doi: 10.1016/j.jasc.2019.08.006. Epub 2019 Sep 28.
7
A 2-year retrospective study on pleural effusions: A cancer centre experience.一项关于胸腔积液的2年回顾性研究:一家癌症中心的经验。
Cytopathology. 2019 Nov;30(6):607-613. doi: 10.1111/cyt.12755. Epub 2019 Sep 9.
8
Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature.我们准备好制定积液细胞学的分级方案了吗?文献综述与分析
Diagn Cytopathol. 2019 Nov;47(11):1145-1159. doi: 10.1002/dc.24278. Epub 2019 Jul 13.
9
Announcement: The International System for Reporting Serous Fluid Cytopathology.公告:浆液性液体细胞病理学报告国际系统
Acta Cytol. 2019;63(5):349-351. doi: 10.1159/000501536. Epub 2019 Jun 24.
10
The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology.国际细胞学会横滨乳腺细针穿刺活检细胞病理学报告系统
Acta Cytol. 2019;63(4):255-256. doi: 10.1159/000501055. Epub 2019 May 28.